Agilera Pharma

Agilera Pharma AS was established in 2023 as a subsidiary of IFE, with an organization of 140 employees. Agilera operates in three business areas: CDMO: A development partner for innovative radiopharmaceuticals tailored to customer needs, from early stages to clinical production. CMO: Large-scale production and distribution of a major pharmaceutical company’s commercial radiopharmaceutical therapies across more than 30 countries. Licensed by the Norwegian Medicines Agency and GMP certified. Wholesaler and Distributor: Agilera is the national radiopharmaceutical wholesaler in Norway. Agilera holds the central pharmacy function for radiopharmaceuticals and serves as the logistics hub for distributing radiopharmaceuticals in Norway and globally.